From Chancellor's Gallaghers update to the Board of Trustees Friday, as reported in the University Times:
Budget:
The University had $50 million in expenses related to the pandemic, including $18 million for student refunds, $27 million in lost revenue in other areas and $13 million to prepare the campuses to transition to accommodate students, staff and faculty during the pandemic.
Research funding was up slightly, while money from tuition and fees and the return on investments have remained stable.
Enrollment:
Undergrad enrollment was up 6.6%. Out-of-state freshman accounted for 42.7% of incoming freshman class. Graduate enrollment was down 1.7 percent overall. The biggest hit was among international students, which were down 17 percent, largely because of traveling difficulties during the pandemic. This was offset somewhat by a 3 percent increase in domestic graduate students.
The regional campuses all had slight enrollment declines, most significantly among Pell Grant students.
Award winners:
A record 14 students from Pitt were named Fulbright Scholars last year, while two other students were awarded the prestigious Harry S. Truman scholarship and Beinecke Scholarship.
COVID Research:
A large clinical study led by Derrick Angus and the Critical Care Medicine department showing definitively that steroids were improving outcomes among critically ill COVID-19 patients. “That work immediately led to a change in World Health Organization treatment recommendations, and that is already making a difference globally, literally saving lives,” Gallagher said.
Three vaccine candidates are under development in Pitt research labs.
Two pharmaceutical companies have partnered with Pitt on clinical trials on their vaccines
The NIH selected Pitt this month to lead a trio of phase three clinical trials, exploring the use of blood thinners to improve outcomes in adult COVID-19 patients at risk of developing blood clots.
Not included was a mention the antibody peptide described last week that is expected to go into clinical trials by January.
Support for Pitt's COVID work here: https://engage.pitt.edu/project/20425
Gallagher also noted that despite the interruptions caused by the pandemic, the Innovation Institute still recorded another record high 394 invention disclosures last fiscal year, and just this week, Pitt’s Small Business Development Center was named the number one such center in the country out of more than 1,000 by the U.S. Small Business Administration.
COVID Numbers:
As of Sept. 25, 51 students remained in isolation. The new positive tests, all from students who sought tests after experiencing symptoms, bring the total to 229 since Aug. 1. Of the more than 3,574 students who’ve participated in surveillance testing since Aug. 12, only 13 have tested positive.
Compared to other schools, Pitt is doing fairly well.
# of cumulative COVID cases since start date:
Pitt: 229 students / 12 employees since Aug. 1
Clemson: 2,428 students / 96 employees since June 5
North Carolina State: 1,067 students / 44 employees since Aug. 8
Notre Dame: 710 students / 17 employees since Aug. 3
Ohio State: 2,803 students / 38 employees since Aug. 1
Penn State: 1,892 students since Aug. 7 / no numbers were reported for symptomatic employees
University of North Carolina: 658 students since July 1 / 70 employees since February
University of Virginia: 590 students / 54 employees since Aug. 17
Virginia Tech: 842 students / 8 employees since Aug. 3
West Virginia University: 583 students / 5 employees since July 20
Budget:
The University had $50 million in expenses related to the pandemic, including $18 million for student refunds, $27 million in lost revenue in other areas and $13 million to prepare the campuses to transition to accommodate students, staff and faculty during the pandemic.
Research funding was up slightly, while money from tuition and fees and the return on investments have remained stable.
Enrollment:
Undergrad enrollment was up 6.6%. Out-of-state freshman accounted for 42.7% of incoming freshman class. Graduate enrollment was down 1.7 percent overall. The biggest hit was among international students, which were down 17 percent, largely because of traveling difficulties during the pandemic. This was offset somewhat by a 3 percent increase in domestic graduate students.
The regional campuses all had slight enrollment declines, most significantly among Pell Grant students.
Award winners:
A record 14 students from Pitt were named Fulbright Scholars last year, while two other students were awarded the prestigious Harry S. Truman scholarship and Beinecke Scholarship.
COVID Research:
A large clinical study led by Derrick Angus and the Critical Care Medicine department showing definitively that steroids were improving outcomes among critically ill COVID-19 patients. “That work immediately led to a change in World Health Organization treatment recommendations, and that is already making a difference globally, literally saving lives,” Gallagher said.
Three vaccine candidates are under development in Pitt research labs.
Two pharmaceutical companies have partnered with Pitt on clinical trials on their vaccines
The NIH selected Pitt this month to lead a trio of phase three clinical trials, exploring the use of blood thinners to improve outcomes in adult COVID-19 patients at risk of developing blood clots.
Not included was a mention the antibody peptide described last week that is expected to go into clinical trials by January.
Support for Pitt's COVID work here: https://engage.pitt.edu/project/20425
Gallagher also noted that despite the interruptions caused by the pandemic, the Innovation Institute still recorded another record high 394 invention disclosures last fiscal year, and just this week, Pitt’s Small Business Development Center was named the number one such center in the country out of more than 1,000 by the U.S. Small Business Administration.
COVID Numbers:
As of Sept. 25, 51 students remained in isolation. The new positive tests, all from students who sought tests after experiencing symptoms, bring the total to 229 since Aug. 1. Of the more than 3,574 students who’ve participated in surveillance testing since Aug. 12, only 13 have tested positive.
Compared to other schools, Pitt is doing fairly well.
# of cumulative COVID cases since start date:
Pitt: 229 students / 12 employees since Aug. 1
Clemson: 2,428 students / 96 employees since June 5
North Carolina State: 1,067 students / 44 employees since Aug. 8
Notre Dame: 710 students / 17 employees since Aug. 3
Ohio State: 2,803 students / 38 employees since Aug. 1
Penn State: 1,892 students since Aug. 7 / no numbers were reported for symptomatic employees
University of North Carolina: 658 students since July 1 / 70 employees since February
University of Virginia: 590 students / 54 employees since Aug. 17
Virginia Tech: 842 students / 8 employees since Aug. 3
West Virginia University: 583 students / 5 employees since July 20
Last edited:
